Inclusion Criteria:~* Mild to moderate Alzheimer's Disease.~* MMSE score of 14 - 22~* CT or MRI within 18
months prior to screening indicating clinical phenotype of Alzheimer's Disease~* Treated daily with donepezil,
rivastigmine or galantamine for â‰¥ 3 months~* All other medications for chronic conditions should have been at a
stable dose for at least 2 weeks prior to first dose.~* No clinically meaningful abnormalities on
electrocardiogram (ECG), physical examination and clinical laboratory tests~
